NuPathe Inc.: Clinical Trials

8 completed. 5 Phase 1, 3 Phase 3.

By phase and status

Phase	Trials	Status
Phase 1	5	Completed 5
Phase 3	3	Completed 3

Follow NuPathe Inc.: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Safety, Pharmacokinetic, and Tolerability Study of Zecuity® in Adolescent Subjects With a History of Acute Migraine PROT-CL-NP101-015.01 - Acute Migraine	Phase 1	Completed	NuPathe Inc.	37	2013-08-01	2016-02-18
Compare PK and Bioavailability of 2 NP101 Patches With Oral Imitrex in Healthy Adults NP101, sumatriptan succinate - Compare Bioequivalence Patches Previously Used in the NP101-007 Study	Phase 1	Completed	NuPathe Inc.	63	2009-12-01	2017-10-12
An Open-Label Study to Evaluate the Safety of NP101 in the Treatment of Acute Migraine Over Twelve Months NP101 - Migraine Disorders	Phase 3	Completed	NuPathe Inc.	514	2009-02-01	2016-02-04
The Efficacy and Tolerability of NP101 Patch in the Treatment of Acute Migraine NP101 - Sumatriptan iontophoretic transdermal patch, Placebo - Migraine Disorders	Phase 3	Completed	NuPathe Inc.	530	2009-01-01	2016-02-04
An Open-Label Study to Evaluate the Safety of NP101 in the Treatment of Acute Migraine Over 12 Months NP101 - Migraine Disorders	Phase 3	Completed	NuPathe Inc.	198	2009-01-01	2016-02-04
Phase I, Open Label, Single-Dose, Four Way Crossover Study to Compare the PK of NP101 With Oral Imitrex® (50mg) in Migraine Subjects During an Acute Migraine Attack and During a Non-Migraine Period Sumatriptan succinate, NP101 Study Patch - Migraine Disorders	Phase 1	Completed	NuPathe Inc.	23	2008-11-01	2016-02-03
Phase I Open Label Single-Dose Study to Compare the Pharmacokinetics of NP101 Healthy Volunteers NP101 Sumatriptan Iontophoretic Transdermal Patch - Migraine Disorders	Phase 1	Completed	NuPathe Inc.	4	2008-06-01	2016-02-03
Phase I Study to Compare NP101(Sumatriptan Iontophoretic Transdermal Patch) With Three Formulations of Imitrex® Sumatriptan succinate - Healthy	Phase 1	Completed	NuPathe Inc.	25	2007-11-01	2016-02-03

Conditions studied

Migraine Disorders (5)

Interventions

Sumatriptan (5)

Countries

United States (7)

Top investigators

Kerri L Wilks, MD, CPI (1)  ·  Mark Pierce, M.D., PhD. (1)  ·  Mark Pierce, MD (1)  ·  Mark Pierce, MD PhD (1)  ·  Shannon Canas, MD (1)  ·  Shannon M Canas, MD (1)  ·  Thomas C Marbury, MD (1)

Results publications

PMID 22352764, PMID 22694484